These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23133467)

  • 1. IL-23 and IL-27 Levels in Macrophages Collected from Peripheral Blood of Patients with Healing Vs Non-Healing Form of Cutaneous Leishmaniasis.
    Tolouei S; Ghaedi K; Khamesipour A; Akbari M; Baghaei M; Hasheminia S; Narimani M; Hejazi Sh
    Iran J Parasitol; 2012; 7(1):18-25. PubMed ID: 23133467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response in cutaneous leishmaniasis patients with healing
    Miramin-Mohammadi A; Javadi A; Eskandari SE; Mortazavi H; Rostami MN; Khamesipour A
    Iran J Microbiol; 2020 Jun; 12(3):249-255. PubMed ID: 32685122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR2 and TLR4 in cutaneous leishmaniasis caused by Leishmania major.
    Tolouei S; Hejazi SH; Ghaedi K; Khamesipour A; Hasheminia SJ
    Scand J Immunol; 2013 Nov; 78(5):478-84. PubMed ID: 23980810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of leishmania isolates from healing and nonhealing cutaneous leishmaniasis patients using internal transcribed spacer region PCR.
    Tolouei S; Hejazi SH; Ghaedi K; Hasheminia SJ
    Jundishapur J Microbiol; 2014 Apr; 7(4):e9529. PubMed ID: 25147707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Th1 and Th2 responses in non-healing and healing patients with cutaneous leishmaniasis.
    Shahi M; Mohajery M; Shamsian SA; Nahrevanian H; Yazdanpanah SM
    Rep Biochem Mol Biol; 2013 Apr; 1(2):43-8. PubMed ID: 26989708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Responses in Cutaneous Leishmaniasis:
    Miramin-Mohammadi A; Javadi A; Eskandari SE; Nateghi-Rostami M; Khamesipour A
    J Arthropod Borne Dis; 2021 Mar; 15(1):126-135. PubMed ID: 34277861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Three Different Therapies for Cutaneous Leishmaniasis and Identification of the Etiologic Isolates in Isfahan, Iran.
    Abdellahi L; Hejazi SH; Amirmozafari N; Sotoodehnejadnematalahi F
    Arch Iran Med; 2020 Nov; 23(11):740-748. PubMed ID: 33220690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCR-RFLP diagnosis and characterization of Leishmania species causing human cutaneous leishmaniasis and evaluation of treatment times with glucantime in these patients.
    Hashemi N; Mohaghegh MA; Hashemi M; Azami M; Mortazavidehkordi N; Hashemi C; Hejazi SH
    Trop Biomed; 2016 Dec; 33(4):689-696. PubMed ID: 33579065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design.
    Moafi M; Rezvan H; Sherkat R; Taleban R; Asilian A; Zarkesh Esfahani SH; Nilforoushzadeh MA; Jaffary F; Feizi A
    BMJ Open; 2017 Jan; 7(1):e013006. PubMed ID: 28132002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The level of interleukin-17, 23, and gamma interferon in cutaneous leishmaniasis patients before and after intra lesion treatment.
    Ghazanfari M; Shahriari B; Rahnama V; Khazaei M; Naderi S; Motazedian MH
    J Parasit Dis; 2022 Jun; 46(2):476-482. PubMed ID: 35692466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis.
    Ramos TD; Silva JD; da Fonseca-Martins AM; da Silveira Pratti JE; Firmino-Cruz L; Maciel-Oliveira D; Dos-Santos JS; Tenorio JIN; de Araujo AF; Freire-de-Lima CG; Diaz BL; Cruz FF; Rocco PRM; de Matos Guedes HL
    Stem Cell Res Ther; 2020 Aug; 11(1):374. PubMed ID: 32867857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis.
    Ajdary S; Riazi-Rad F; Alimohammadian MH; Pakzad SR
    J Infect; 2009 Aug; 59(2):139-43. PubMed ID: 19560211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
    Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
    Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological and immunological differences between zoonotic cutaneous leishmaniasis due to Leishmania major and sporadic cutaneous leishmaniasis due to Leishmania infantum.
    Boussoffara T; Boubaker MS; Ben Ahmed M; Mokni M; Guizani I; Ben Salah A; Louzir H
    Parasite; 2019; 26():9. PubMed ID: 30810524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD26 expression on CD4+T cells in patients with cutaneous leishmaniasis.
    Jafari-Shakib R; Ajdary S; Amiri ZM; Mohammadi AM; Nourijelyani K; Mortazavi H; Shokrgozar MA; Nikbin B; Khamesipour A
    Clin Exp Immunol; 2008 Jul; 153(1):31-6. PubMed ID: 18460019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Comparison of the IFN-ɤ, TNF-α and IL-10 Cytokines in Healing and Non-healing Cutaneous Leishmaniasis.
    Taraghian M; Hanif H; Mousavi P; Cheshmeh ZB; Samei A; Abdollahi A; Vazini H
    Iran J Parasitol; 2021; 16(3):490-498. PubMed ID: 34630595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major.
    Bemani E; Oryan A; Bahrami S
    Exp Parasitol; 2019 Oct; 205():107747. PubMed ID: 31442454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of mesenchymal stem cells on cutaneous leishmaniasis lesions caused by Leishmania major.
    Navard SH; Rezvan H; Haddad MHF; Ali SA; Nourian A; Eslaminejad MB; Behmanesh MA
    J Glob Antimicrob Resist; 2020 Dec; 23():243-250. PubMed ID: 32977079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected co-detection of promastigote and amastigote Leishmania forms in a human cutaneous lesion: implications for leishmaniasis physiopathology and treatment.
    Haouas N; Remadi L; Chaara D; Chargui N; Dabghi R; Jbeniani H; Babba H; Ravel C
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):18-20. PubMed ID: 25312011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.